HEPION PHARMACEUTICALS, INC. Investing Cash Flow
HEPION PHARMACEUTICALS, INC. (HEPA) reported Investing Cash Flow of -$132.12 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-13
- HEPION PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $0.00.
- HEPION PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00.
- HEPION PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for the quarter ending 2024-12-31 was $0.00.
- HEPION PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for the quarter ending 2024-03-31 was $0.00.
- HEPION PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$132.12K.
- HEPION PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$600.00K.
- HEPION PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$14.30K.
- HEPION PHARMACEUTICALS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$14.07K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | -$132.12K 10-K · filed 2026-03-12 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$132.12K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | -$132.12K 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$600.00K 10-K · filed 2026-03-12 | ||
| 2024-09-30 | -$600.00K 10-Q · filed 2025-11-12 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-21 | -$348.00 derived: sum of 2 quarters · filed 2025-04-08 | $2.23K derived: sum of 3 quarters · filed 2025-04-08 | -$14.30K derived: sum of 4 quarters · filed 2025-04-08 |
| 2023-12-31 | -$348.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-08 | $2.23K derived: sum of 2 quarters · filed 2025-04-08 | -$14.30K derived: sum of 3 quarters · filed 2025-04-08 | -$14.30K 10-K · filed 2025-04-08 |
| 2023-09-30 | $2.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$13.96K derived: sum of 2 quarters · filed 2024-11-14 | -$13.96K 10-Q · filed 2024-11-14 | -$30.29K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$16.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$16.54K 10-Q · filed 2024-08-13 | -$32.87K derived: sum of 3 quarters · filed 2024-08-13 | -$32.87K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-21 | -$16.34K derived: sum of 2 quarters · filed 2024-05-21 | -$16.34K derived: sum of 3 quarters · filed 2024-05-21 | -$14.07K derived: sum of 4 quarters · filed 2024-05-21 |
| 2022-12-31 | -$16.34K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$16.34K derived: sum of 2 quarters · filed 2024-04-16 | -$14.07K derived: sum of 3 quarters · filed 2024-04-16 | -$14.07K 10-K · filed 2024-04-16 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $2.27K derived: sum of 2 quarters · filed 2023-11-20 | $2.27K 10-Q · filed 2023-11-20 | $2.27K derived: sum of 4 quarters · filed 2023-11-20 |
| 2022-06-30 | $2.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.27K 10-Q · filed 2023-08-14 | $2.27K derived: sum of 3 quarters · filed 2023-08-14 | -$34.22K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | $1.00 derived: sum of 2 quarters · filed 2023-05-12 | -$36.48K derived: sum of 3 quarters · filed 2023-05-12 | -$48.30K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-10 | -$36.48K derived: sum of 2 quarters · filed 2023-04-10 | -$48.30K derived: sum of 3 quarters · filed 2023-04-10 | -$130.41K 10-K · filed 2023-04-10 |
| 2021-09-30 | -$36.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$48.30K derived: sum of 2 quarters · filed 2022-11-14 | -$130.41K 10-Q · filed 2022-11-14 | -$206.95K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$11.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$93.92K 10-Q · filed 2022-08-15 | -$170.47K derived: sum of 3 quarters · filed 2022-08-15 | -$170.47K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$82.11K 10-Q · filed 2022-05-16 | -$158.65K derived: sum of 2 quarters · filed 2022-05-16 | -$158.65K derived: sum of 3 quarters · filed 2022-05-16 | -$170.09K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$76.55K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | -$76.55K derived: sum of 2 quarters · filed 2022-04-08 | -$87.98K derived: sum of 3 quarters · filed 2022-04-08 | -$85.79K 10-K · filed 2022-04-08 |
| 2020-09-30 | -$1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$11.44K derived: sum of 2 quarters · filed 2021-11-15 | -$9.24K 10-Q · filed 2021-11-15 | -$15.38K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$11.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$9.24K 10-Q · filed 2021-08-16 | -$15.38K derived: sum of 3 quarters · filed 2021-08-16 | -$15.38K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $2.19K 10-Q · filed 2021-05-14 | -$3.94K derived: sum of 2 quarters · filed 2021-05-14 | -$3.94K derived: sum of 3 quarters · filed 2021-05-14 | -$11.43K derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | -$6.13K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$6.13K derived: sum of 2 quarters · filed 2021-03-31 | -$13.62K derived: sum of 3 quarters · filed 2021-03-31 | -$51.47K 10-K · filed 2021-03-31 |
| 2019-09-30 | -$2.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$7.49K derived: sum of 2 quarters · filed 2020-11-16 | -$45.34K 10-Q · filed 2020-11-16 | -$45.34K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | -$7.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$45.33K 10-Q · filed 2020-08-12 | -$45.33K derived: sum of 3 quarters · filed 2020-08-12 | -$45.33K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | -$37.85K 10-Q · filed 2020-06-29 | -$37.85K derived: sum of 2 quarters · filed 2020-06-29 | -$37.85K derived: sum of 3 quarters · filed 2020-06-29 | -$37.85K derived: sum of 4 quarters · filed 2020-06-29 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-14 | $0.00 derived: sum of 2 quarters · filed 2020-05-14 | $0.00 derived: sum of 3 quarters · filed 2020-05-14 | $900.00 10-K · filed 2020-05-14 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $900.00 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $900.00 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $900.00 10-Q · filed 2019-05-15 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$2.42K 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | -$2.42K 10-Q · filed 2018-08-14 | -$14.71K 10-K · filed 2019-03-14 | ||
| 2016-06-30 | -$502.21K 10-KT · filed 2018-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |